Home › Free Stock Grades › IDYA
IDEAYA Biosciences, Inc. (IDYA) Stock Grade
IDYA · Healthcare
C
Market Cap
$3.6B
P/E Ratio
—
Revenue Growth (YoY)
+3024.4%
Net Margin
-52.0%
Return on Equity
—
Dividend Yield
None
About IDEAYA Biosciences, Inc.'s fundamentals
IDEAYA Biosciences is a $3.6 billion biotechnology company experiencing exceptional revenue growth of 3,024% year-over-year, indicating rapidly expanding commercial activity. However, the company operates at a significant loss with a net margin of -52%, meaning it loses 52 cents on every dollar of revenue generated. The company pays no dividend and reported a net loss in its latest annual statement, reflecting the capital-intensive nature of early-stage biotech development as the company scales its operations.